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ABSTRACT
A case of metastatic melanoma of the antrum and duodenal bulb is reported with rare endoscopic find-
ings. A 59-year-old male patient was presented with nausea, vomiting, and abdominal pain one year after
excision of malignant melanoma from the back. The tumor was classified as Clark IV, Breslow III. Upper
gastrointestinal endoscopy revealed one melanotic polypoid mass with ulcerations at the tip in the
antrum and two in the duodenal bulb. Endoscopic biopsy of these polypoid masses showed malignant
melanoma metastases. Patients with gastrointestinal symptoms and a history of melanoma should be
investigated for the presence of gastrointestinal metastases even if the original primary malignancy was
diagnosed years prior to the patient presentation.
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INTRODUCTION 
S
econdary neoplasms of the stomach are rare and often present clinical and diagnostic
problems. Malignant melanoma is an uncommon malignancy and it is the most com-
mon tumor that metastasizes to the gastrointestinal tract (GIT) (1,2). Malignant melanoma
metastases in GIT are detected clinically in only 2% of the cases. However, they are found
in more than 60% of autopsies on patients who have died with disseminated melanoma.
The small bowel is the most common intestinal site for metastases (3). Information on gas-
tric and duodenal metastases, however, is merely limited to single case reports. 
We report very rare endoscopic findings of malignant melanoma metastases in the gastric
antrum and duodenal bulb.   
CASE REPORT
A 59-year-old man was admitted to the Clinic for Gastroenterology and Hepatology with a
5-day history of nausea, vomiting, and abdominal pain. His past medical history was sig-
nificant for skin melanoma of the right side of the back. The tumor had been completely
excised one year before, and microscopic examination confirmed a diagnosis of malignant
melanoma, Clark IV, Breslow III.
Physical examination revealed lymph nodes enlargement in the right axilla and epigastric
pain on palpation. Laboratory data showed white blood cell count, hematocrit, serum elec-
trolytes, BUN, creatinine and liver enzymes within normal limits. Abdominal ultrasonogra-
phy showed liver steatosis with no evidence of liver or intraabdominal metastases. A chest
x-ray and brain computer tomography was unremarkable for metastases.
Upper gastrointestinal endoscopy revealed two melanotic polypoid mass with ulcerations at
the tip in the antrum (Figure 1) and one in the duodenal bulb (Figure 2). Endoscopic biop-
sy of these polypoid masses showed malignant melanoma metastases (Figure 3). 
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Figure 1. Polipoid melanotic mass with tip ulceration in the antrum
Figure 2. Polipoid melanotic mass with tip ulceration in the duodenal bulbDISCUSSION
Malignant melanoma is the most common tumor that metastasizes to the GIT (1-3). The
average rate of GIT metastases detected clinically in malignant melanoma patients ante-
mortem is only 2.3%, but varies from 0.8% to 8.9% in different series (3,4). The overall inci-
dence of GIT metastases detected post mortem in autopsies of patients who died from dis-
seminated malignant melanoma is in excess of 60% of the cases (3,5). The most common
site of GIT melanoma metastasis is the small bowel (35%-97%) (6-8). The stomach and
duodenum are involved in 5%-50% of the cases (1,2). Malignant melanoma is the most fre-
quent tumor to metastasize to the stomach (29.6%) (3). One third of patients with metas-
tases have two or more parts of the GIT involved.   
The primary melanoma in patients with GIT metastases is typically located in the extremi-
ties (15%-57% of the cases) and trunk (13%-54%), and less frequently in the head and neck
(5%-33%) (4). Primary lesion is occult in 10%-26% of the cases (4). The risk of melanoma
spread to the GIT is higher among patients with a primary lesion classified as Clark III or
above, occurring in 70%-100% of such patients, whereas it occurs in 5%-24% of the
patients with Clark II and 0%-6% of the patients with Clark I. These characteristics are con-
sistent with our patient, whose primary melanoma was located on the back and graded as
Clark IV, Breslow III. 
The average time from the diagnosis of the primary tumor to the detection of GIT metas-
tases is 43.8–11.3 (range 21.6-54) months (5). It varies from 2 months up to 12 years.
Metastases to the GIT have been reported up to 21 years after the initial presentation of the
melanoma.
Metastatic melanoma of the stomach may be presented with vague gastrointestinal symp-
toms, nausea, vomiting, abdominal pain, gastrointestinal bleeding, and weight loss (5). The
median duration of symptoms of GIT metastases ranges from 2 to 5.5 months. 
Endoscopy is useful in the diagnosis and local treatment of gastric metastasis. Endoscopic
appearances of metastases might take one of several forms: multiple small submucosal
nodules, a polipoid mass, ulceration, and large extrinsic tumor mass. These lesions could
be melanotic and easily recognizable or amelanotic and therefore difficult to differentiate
from other sources of metastases or tumors, e.g. mucosa-associated lymphoid tissue
(MALT) lymphoma. Endoscopic biopsies are especially recommended in amelanotic
metastases, which may be expected in up to 50% of cases. Biopsies confirmed the diag-
nosis of melanoma in only 65% of the cases on one series. Tumor negative biopsies may
be explained by sampling error or submucosal localization, a region not accessible to the
endoscopic biopsy forceps.   
Radiologically, GIT metastases can appear as polypoid lesions, ulcerating lesions with cav-
itation, submucosal nodules or diffuse thickening of the intestinal wall. A classic radiologi-
cal appearance is that of a ￿bull￿s eye￿ which is seen when barium fills a central ulcer in a
metastatic nodule.  
The prognosis of patients with distant metastatic disease is very poor. Patients with gas-
trointestinal metastases have a median survival period of 12.5 months and an estimated 5-
year survival rate of 14%.  
Patients with gastrointestinal symptoms and a history of melanoma should be examined for
the presence of GIT metastases even if the original primary malignancy had been diagnosed
years prior to the patient presentation.
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Figure 3. Metastatic melanoma. The melanoma cells exhibit marked nuclear and cytoplas-
mic pleomorphism and frequent mitoses; many cells contain severe amounts of melanin
pigment